Literature DB >> 6122692

Midazolam determination by gas chromatography, liquid chromatography and gas chromatography--mass spectrometry.

J V Vasiliades, T Sahawneh.   

Abstract

Midazolam is determined in serum by gas chromatography with a nitrogen-selective detector, by liquid chromatography, and by gas chromatography--mass spectrometry. Comparable results are obtained with the three techniques with a within-run precision of 9% by gas chromatography and gas chromatography---mass spectrometry and 5% by liquid chromatography. Between-run precision is 13% by gas chromatography--mass spectrometry and 10% by liquid chromatography. Comparison of patient's sera by gas chromatography (x), liquid chromatography (y), and by gas chromatography (x), gas chromatography--mass spectrometry (y) gave correlations of 0.98 and 0.89, respectively. Interferences observed when using one technique, for example liquid chromatography, can be eliminated by analyzing the sample extract with one of the other techniques.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122692     DOI: 10.1016/s0378-4347(00)80432-6

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Pharmacokinetics of midazolam in critically ill pediatric patients.

Authors:  M C Nahara; J McMorrow; P R Jones; D Anglin; R Rosenberg
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Jul-Dec       Impact factor: 2.441

2.  Assay of midazolam and brotizolam in plasma by a gas chromatographic and a radioreceptor technique.

Authors:  R Jochemsen; P A Van Rijn; T G Hazelzet; D D Breimer
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

Review 3.  Clinical pharmacokinetics of the newer benzodiazepines.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; H R Ochs; R I Shader
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

Review 4.  Midazolam. A review of its pharmacological properties and therapeutic use.

Authors:  J W Dundee; N J Halliday; K W Harper; R N Brogden
Journal:  Drugs       Date:  1984-12       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.